ALAB Astera Labs, Inc.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1736297 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY115.2%
TTM net income YoY132.0%
TTM EPS YoY107.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin73.9%
Operating margin25.5%
Net margin29.6%
FCF margin22.1%
EBITDA margin26.5%
Returns
ROE28.2%
ROA24.9%
ROIC (approx.)27.2%
Asset turnover0.84x
Leverage & solvency
Liabilities / assets13.1%
Debt / equity0.00x
Current ratio8.03x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.95x
Accruals ratio1.3%
Payout ratio—
Capex / revenue5.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $852.52M | $396.29M |
| Cost of revenue | $207.26M | $93.59M |
| Gross profit | $645.26M | $302.70M |
| R&D expense | $304.00M | $200.83M |
| SG&A expense | $88.07M | $94.28M |
| Operating income | $173.42M | -$116.07M |
| Pretax income | $218.15M | -$81.78M |
| Income tax | -$981,000 | $1.64M |
| Net income | $219.13M | -$83.42M |
| EBITDA | $180.25M | -$112.91M |
| EPS (basic) | 1.32 | -0.64 |
| EPS (diluted) | 1.22 | -0.64 |
| Weighted avg. shares (diluted) | 179.55M | 131.26M |
| Balance sheet | ||
| Cash & equivalents | $167.61M | $80.04M |
| Short-term investments | $1.02B | $834.75M |
| Receivables | $83.20M | $38.81M |
| Inventory | $58.98M | $43.22M |
| Current assets | $1.36B | $1.01B |
| PP&E, net | $92.04M | $35.65M |
| Goodwill | $19.02M | — |
| Total assets | $1.53B | $1.05B |
| Current liabilities | $133.04M | $86.54M |
| Total liabilities | $168.19M | $89.71M |
| Shareholders' equity | $1.36B | $964.80M |
| Shares outstanding | 170.19M | 162.02M |
| Cash flow statement | ||
| Operating cash flow | $319.31M | $136.68M |
| Capital expenditure | $37.54M | $34.24M |
| Free cash flow | $281.76M | $102.43M |
| Investing cash flow | -$241.47M | -$757.57M |
| Financing cash flow | $9.80M | $655.84M |
| Depreciation & amortization | $6.83M | $3.15M |
| Stock-based compensation | $160.03M | $234.59M |
| Share buybacks | $0 | $1.07M |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.